Community/Retail

Officials with the FDA have approved pertuzumab (Perjeta, Roche) in combination with trastuzumab and chemotherapy as an adjuvant therapy for patients with early-stage human epidermal growth factor receptor 2 positive (HER2+) breast cancer who are at high risk of experiencing recurrence.

The cornerstone of working with patients is sharing decision-making and presenting information in a way that helps patients understand the risks and benefits of various choices.

Health care providers can administer egg-based influenza vaccines to people with egg allergy without taking precautions, according to a newly-updated influenza vaccine practice parameter from the Influenza Vaccine and Egg Allergy Practice Parameter Workgroup commissioned by Joint Task Force on Practice Parameters (JTFPP).

Danielle McDonald, PharmD, talks about her residency at Rutgers, the State University of New Jersey.

Rattlesnake pills have received media attention due to their link with Salmonella infection.

HMG-CoA reductase inhibitors are a class of lipid-lowering medications. Here is a look at guidelines and studies for health care professionals.

Officials with the FDA have approved ertugliflozin (Steglatro, Merck and Pfizer) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Officials with the FDA have finalized a rule that bans 24 active ingredients, including triclosan, from being marketed and sold in OTC health care antiseptic products.

Ready to achieve big goals in the new year? Here is how to avoid common pitfalls.

To prepare for USP Chapter , pharmacies must ensure that they are meeting the right compounding compliance standards.

Officials with Allergan and Gedeon Richter are reporting positive topline results for a phase 3 study of cariprazine (Vraylar) for the treatment of adults with bipolar I depression.

The established therapeutic dosing for gabapentin in neuropathic pain is 1800-3600 mg/day in 3 divided doses in patients with normal renal function.

For people on a specific nutrition plan, how do you navigate the festivities and enjoy them?

Officials with the FDA have approved voretigene neparvovec-rzyl (Luxturna, Spark Therapeutics), the first novel gene therapy for the treatment of an inherited form of vision loss in children and adults, according to an FDA press release.

FDA officials are now requiring a new patient medication guide, providing educational information that every patient will be asked to read before receiving a GBCA, and they are requiring manufacturers of GBCAs to conduct human and animal studies to further assess the safety of these contrast agents.

Planning and consuming a diet that meets all of the recommended dietary guidelines for Americans is a challenge for most people.

Pharmacists should be aware of what components they need to address to comply in order to prep themselves for USP standards.

Check out this exclusive interview with the guy behind 'Excuse Me, This Is a PHARMACY, Not a Fast Food Restaurant!'

Netarsudil ophthalmic solution 0.02%, is a novel once-daily eye drop believed to reduce IOP by increasing the outflow of aqueous humor through the trabecular meshwork, the main fluid drain of the eye.

To protect consumers from potentially harmful homeopathic drug products, the FDA has proposed a new, risk-based enforcement approach, according to an FDA statement.

A look at how the digital landscape could change after a merger between an insurer and giant retail pharmacy company is finalized.

A consensus document has been published, which gives clinicians the first set of viable guidelines to follow.

The match for residency programs is a competitive process.

It can be daunting for parents to see their child vomiting, especially when this occurs in the evening after the pediatrician's office may be closed.

What you need to know.

The FDA approval was based on data from the phase 3 Oral Psoriatic Arthritis Trial (OPAL) clinical development program.

American pharmacies across the nation are struggling as a result of pharmacy benefit manager (PBM) practices.

Adolescents and young adults who are living with HIV and were exposed to the virus perinatally have a unique risk of nonadherence in adolescence, as well as an elevated risk of mental health and substance use problems.

Learn about the new products and expanded indications approved by the FDA in November 2017.

What does it take to move the small but important proportion of those who refuse or delay immunization away from skepticism and into acceptance?